DRG Market Assessment reports

Glucagon-like peptide-1 receptor agonist (GLP-1 RA) products like Novo Nordisk’s semaglutide SC (Ozempic / Wegovy) and Eli Lilly’s tirzepatide (Mounjaro / Zepbound) have gained popularity in…

Clarivate Epidemiology’s coverage of dyslipidemia comprises epidemiological estimates of key patient populations in 45 countries worldwide. We report the prevalence of dyslipidemia for each country…

Clarivate Epidemiology’s coverage of dyslipidemia comprises epidemiological estimates of key patient populations in 45 countries worldwide. We report the prevalence of dyslipidemia for each country…

Clarivate’s Extrapolated Worldwide Coverage is the first and only evidence-based data set of epidemiological forecasts for key dyslipidemia patient populations, covering 171 countries and more…

Clarivate Epidemiology’s coverage of dyslipidemia comprises epidemiological estimates of key patient populations in 45 countries worldwide. We report the prevalence of dyslipidemia for each country…

Clarivate Epidemiology’s coverage of malignant pleural mesothelioma (MPM) comprises epidemiological estimates of key patient populations in the major mature pharmaceutical markets (the United…

Clarivate Epidemiology’s coverage of mesothelioma comprises epidemiological estimates of key patient populations in the major mature pharmaceutical markets (the United States, France, Germany,…

Clarivate Epidemiology’s coverage of CLL / SLL comprises epidemiological estimates of key patient populations in 45 countries worldwide. We report both the diagnosed incidence and diagnosed…

Clarivate’s Extrapolated Worldwide Coverage is the first and only evidence-based data set of epidemiological forecasts for key CLL / SLLpatient populations, covering 171 countries and more than…

Clarivate Epidemiology’s coverage of chronic lymphocytic leukemia and small lymphocytic lymphoma (CLL / SLL) comprises epidemiological estimates of key patient populations in 45 countries…

Clarivate Epidemiology’s coverage of chronic lymphocytic leukemia and small lymphocytic lemphoma (CLL / SLL) comprises epidemiological estimates of key patient populations in 45 countries…

Clarivate Epidemiology’s coverage of chronic lymphocytic leukemia and small lymphocytic lymphoma (CLL / SLL) comprises epidemiological estimates of key patient populations in 45 countries…